These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21382170)

  • 21. [Beta-thalassemia: clinical manifestations].
    Perrimond H
    Bull Soc Pathol Exot; 2001 May; 94(2):92-4. PubMed ID: 11475035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein C and S levels in patients with Thalassemia intermedia.
    Mohammed NS
    J Med Life; 2022 Nov; 15(11):1415-1418. PubMed ID: 36567848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thalassemia intermedia: revisited.
    Taher A; Isma'eel H; Cappellini MD
    Blood Cells Mol Dis; 2006; 37(1):12-20. PubMed ID: 16737833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of autoimmune hemolytic anemia in beta-thalassemia patients with underlying red blood cells autoantibodies.
    Khaled MB; Ouederni M; Sahli N; Dhouib N; Abdelaziz AB; Rekaya S; Kouki R; Kaabi H; Slama H; Mellouli F; Bejaoui M
    Blood Cells Mol Dis; 2019 Nov; 79():102342. PubMed ID: 31302454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myelofibrosis: a cause of increased transfusion requirement in a child with β-thalassemia intermedia.
    Nirupam N; Maheshwari A; Rath B; Chandra J; Kumar P; Basu S; Nangia A
    J Pediatr Hematol Oncol; 2012 Mar; 34(2):143-5. PubMed ID: 22009011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between primary Sjögren's syndrome, cardiovascular and cerebrovascular disease: a systematic review and meta-analysis.
    Yong WC; Sanguankeo A; Upala S
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):190-197. PubMed ID: 29600936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of beta(0)-thalassemia on the phenotypic expression of heterozygous familial hypercholesterolemia : a study of patients with familial hypercholesterolemia from Sardinia.
    Deiana L; Garuti R; Pes GM; Carru C; Errigo A; Rolleri M; Pisciotta L; Masturzo P; Cantafora A; Calandra S; Bertolini S
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):236-43. PubMed ID: 10634824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pregnancy outcomes among women with beta-thalassemia trait.
    Charoenboon C; Jatavan P; Traisrisilp K; Tongsong T
    Arch Gynecol Obstet; 2016 Apr; 293(4):771-4. PubMed ID: 26476831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk Factors for the Occurrence of Asymptomatic Brain Lesions in Patients with β-Thalassemia: a Systematic Review and Meta-Analysis.
    Haghpanah S; Hosseini-Bensenjan M; Sayadi M; Karimi M; Ramzi M; Movahed H; Eghtedari M
    Clin Lab; 2023 Jun; 69(6):. PubMed ID: 37307134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thromboembolic complications in beta-thalassemia: Beyond the horizon.
    Panigrahi I; Agarwal S
    Thromb Res; 2007; 120(6):783-9. PubMed ID: 17346783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran.
    Taher A; Isma'eel H; Mehio G; Bignamini D; Kattamis A; Rachmilewitz EA; Cappellini MD
    Thromb Haemost; 2006 Oct; 96(4):488-91. PubMed ID: 17003927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coagulation and splenectomy: an overview.
    Cappellini MD; Grespi E; Cassinerio E; Bignamini D; Fiorelli G
    Ann N Y Acad Sci; 2005; 1054():317-24. PubMed ID: 16339680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormone therapy for preventing cardiovascular disease in post-menopausal women.
    Boardman HM; Hartley L; Eisinga A; Main C; Roqué i Figuls M; Bonfill Cosp X; Gabriel Sanchez R; Knight B
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD002229. PubMed ID: 25754617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of venous and arterial thromboembolic events in women with advanced breast cancer treated with CDK 4/6 inhibitors: A systematic review and meta-analysis.
    Bolzacchini E; Pomero F; Fazio M; Civitelli C; Fabro G; Pellegrino D; Giordano M; Squizzato A
    Thromb Res; 2021 Dec; 208():190-197. PubMed ID: 34814055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and Management of β-Thalassemia in India.
    Yadav SS; Panchal P; Menon KC
    Hemoglobin; 2022 Jan; 46(1):27-32. PubMed ID: 35129043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thromboelastometry profile in children with beta-thalassemia.
    Turhan AB; Bör Ö; Akay OM; Akgün NA
    Int J Hematol; 2014 Apr; 99(4):407-12. PubMed ID: 24609765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fracture prevalence in thalassemia: a systematic review and meta-analysis.
    Charoenngam N; Rittiphairoj T; Ponvilawan B
    Arch Osteoporos; 2021 Nov; 16(1):171. PubMed ID: 34773506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Digital thermography and vascular involvement in β-thalassemia intermedia.
    Abdulhai F; Jaffa MA; Elias J; Zakka P; Hotait M; Bou-Fakhredin R; Arnaout S; Taher AT; Refaat MM
    Ann Hematol; 2021 Oct; 100(10):2471-2477. PubMed ID: 34235558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Factors of Arterial Events in Patients with Venous Thromboembolism: A Systematic Review and Meta-Analysis.
    Noumegni SR; Hoffmann C; Tromeur C; Didier R; Bressollette L; Lacut K; Couturaud F
    Thromb Haemost; 2022 Apr; 122(4):590-599. PubMed ID: 34264517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Assessment of iron status in individuals with heterozygotic beta-thalassemia].
    da Fonseca SF; Kimura EY; Kerbauy J
    Rev Assoc Med Bras (1992); 1995; 41(3):203-6. PubMed ID: 8574230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.